Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.89
-0.26%
Mkt Cap $50.56M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | — | — | — | -$0.31 | -$0.39 | -26.46% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.36 | -$0.37 | -2.78% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.36 | -$0.32 | +11.11% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.47 | -$0.32 | +31.91% | — | — |
| Q1 2025 Mar 21, 2025 | — | — | — | -$0.38 | -$0.43 | -13.16% | — | — |
| Q4 2024 Nov 8, 2024 | — | — | — | -$0.53 | -$0.97 | -83.02% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.63 | -$0.44 | +30.16% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.87 | -$0.72 | +17.24% | — | — |
| Q1 2024 Mar 29, 2024 | — | — | — | -$1.35 | -$1.09 | +19.26% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$1.09 | -$1.63 | -49.54% | — | — |
| Q3 2023 Aug 15, 2023 | — | — | — | -$1.14 | -$1.07 | +6.14% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.85 | -$1.19 | -40.00% | — | — |
| Q2 2023 Apr 3, 2023 | — | — | — | -$1.05 | -$0.38 | +63.81% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$1.01 | -$0.93 | +7.92% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.64 | -$1.07 | -67.19% | — | — |
| Q2 2022 May 4, 2022 | — | — | — | -$0.58 | -$0.72 | -24.14% | — | — |
| Q1 2022 Mar 2, 2022 | — | — | — | -$0.25 | -$0.75 | -200.00% | — | — |
| Q4 2021 Nov 3, 2021 | — | — | — | -$0.44 | -$0.35 | +20.45% | — | — |
| Q3 2021 Jul 28, 2021 | — | — | — | -$0.37 | -$0.34 | +8.11% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | — | -$0.46 | — | — | — |